In the DZL, doctors and scientists are concerned primarily with diseases that are today still considered to be incurable and therefore pursue concrete aims for the individual symptoms. Knowledge gained from basic research, for example, should be used in the development of biomarkers for improved phenotyping of patients and these, in turn, should influence the development of new therapies.